Hyperlactataemia syndromes associated with HIV therapy

Author： Ogedegbe A.-E.O.   Thomas D.L.   Diehl A.M.  

Publisher： Elsevier

ISSN： 1473-3099

Source： The Lancet Infectious Diseases, Vol.3, Iss.6, 2003-06, pp. : 329-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Art therapy for relief of symptoms associated with HIV/AIDS

By Rao Deepa   Nainis Nancy   Williams Lisa   Langner Daughon   Eisin Audra   Paice Judith  

AIDS Care, Vol. 21, Iss. 1, 2009-01 ,pp. : 64-69

Routledge Ltd

Access to resources Recommend Favorite

Rituximab therapy for HIV-associated multicentric Castleman disease

By Veraitch Ophelia   Bower Mark   Shackleton David   Stebbing Justin  

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 281-284

Future Medicine

Access to resources Recommend Favorite

When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 3, 2013-06 ,pp. : 193-199

Bentham Science Publishers

Access to resources Recommend Favorite

Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems

By Kim T. W.   Palepu A.   Cheng D. M.   Libman H.   Saitz R.   Samet J. H.  

AIDS Care, Vol. 19, Iss. 8, 2007-09 ,pp. : 1039-1047

Routledge Ltd

Access to resources Recommend Favorite

Effects of Highly Active Antiretroviral Therapy on HIV-1-Associated Oral Complications

By  

Current HIV Research, Vol. 5, Iss. 3, 2007-05 ,pp. : 281-292

Bentham Science Publishers

Access to resources Recommend Favorite